

Dr. Matthew Nielsen
Urologic Oncologist
1 Podcast on BackTable
Dr. Matthew Nielsen is an academic urologic oncologist at the University of North Carolina Medical School in Durham, North Carolina.
Learn from the experiences and expertise of Dr. Matthew Nielsen and other leading voices in your specialty on the BackTable app.

Episode # 187 • 03 Sept 2024
Urology Trends: AUA 2023 Census Report Highlights
Hot off the press! The results of the 2023 American Urological Association Census findings will likely surprise listeners. In this episode of the BackTable Urology Podcast, host Dr. Suzette Sutherland is joined by Dr. Amanda North (The Children’s Hospital at Montefiore) and Dr. Matt Nielsen (University of North Carolina) to dive deep into the census data and offer a call to action for all urologists.
More from Dr. Matthew Nielsen
About
Matthew Nielsen, MD received his medical degree from The Johns Hopkins University School of Medicine and completed his residency at the Brady Urological Institute of The Johns Hopkins Hospital. After residency, Dr. Nielsen served on the faculty at Johns Hopkins prior to joining the UNC Urology faculty in 2009. In addition to his position as Rhodes Distinguished Professor and Chair of the UNC Department of Urology, Dr. Nielsen also serves as an Adjunct Professor in the Departments of Epidemiology and Health Policy & Management at the UNC Gillings School of Global Public Health.
Dr. Nielsen’s clinical practice is focused in urologic oncology—in particular, the treatment of bladder and prostate cancer. He is a member of the integrated Multidisciplinary Genitourinary Oncology Group at the Lineberger Comprehensive Cancer Center, serving as Director of the Division of Urologic Oncology from 2013-2018. Dr. Nielsen is committed to providing compassionate, individualized, patient-centered care, and has been selected by his peers to be named among the Best Doctors in America in Urology since 2013. He received the UNC Health Care Physician Friend of Nursing Award in 2017 and the H. Fleming Fuller Award in 2022. His research in medical decision making, cancer care quality and treatment outcomes has been funded by the National Institutes of Health, the Agency for Healthcare Research and Quality and The American Cancer Society, and nationally recognized by the Rising Stars in Urology Research Award.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.